The nature of antiviral CD8 + t cells associated with protective and pathogenic herpes simplex virus type 1 (HSV-1) infections remains unclear. We compared the transcriptome, phenotype, and function of memory CD8 + T cells, sharing the same HSV-1 epitope-specificities, from infected HLA-A*0201 positive symptomatic (SYMP) vs. asymptomatic (ASYMP) individuals and HLA-A*0201 transgenic rabbits. Compared to higher frequencies of multifunctional effector memory CD8 + t eM cells in ASYMP individuals, the SYMP individuals presented dysfunctional CD8 + t eM cells, expressing major exhaustion pathways. Compared to protected ASYMP HLA transgenic rabbits, the trigeminal ganglia of nonprotected SYMP HLA transgenic rabbits had higher frequencies of dysfunctional tissue-resident CD8 + t RM cells. Moreover, blockade of T cell exhaustion pathways restored the function of CD8 + t cells, reduced virus reactivation, and diminished recurrent disease in HLA transgenic rabbits. these findings reveal unique molecular signatures of protective CD8 + t cells and pave the way for t-cell-based immunotherapy to combat recurrent ocular herpes. Herpes simplex virus type 1 (HSV-1), known to cause a wide range of diseases throughout an individual's lifetime, is carried by a staggering 3.72 billion individuals worldwide 1. Following ocular or oro-facial acute infection, HSV-1 enters the axon of sensory neurons that innervate the eyes and the mouth mucocutaneous tissues, and travel in a retrograde fashion to neuronal cell bodies of the trigeminal ganglion (TG), which becomes the site for HSV latency 2-8. Physical, chemical, and emotional stressors trigger virus reactivation from latently infected TG, which then sheds in tears, and can cause a spectrum of recurrent ocular diseases 9-12. Fortunately, virus shedding in tears is not harmful in the majority of seropositive asymptomatic (ASYMP) individuals 13. However, in a minority of seropositive symptomatic (SYMP) individuals, the virus shedding in tears and re-infection of the eyes can develop into serious recurrent ocular diseases, including potentially blinding herpetic keratitis 14-26. Crosstalk between HSV-1 and CD8 + T cells restrains virus reactivation within the latently-infected TG 2,3,5,6,27. The adaptive immunity plays a role in establishing latency as a high number of activated CD8 + T cells expressing a late effector memory phenotype were found to reside in latently infected TG. This indicates that activated late effector memory CD8 + T cells may control HSV-1 latency 7. Functional antiviral CD8 + T cells, specific to multiple HSV-1 epitopes, are selectively retained and patrol latently-infected TG 2,5,6. In contrast, dysfunctional HSVspecific CD8 + T cells appeared unable to control virus reactivation from latently infected TG, thus contributing to frequent virus shedding in tears as well as to frequent and severe recurrent herpes in SYMP individuals 5,28 .